bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

MannKind Corporation announced that it was informed today by the Food and Drug Administration that the FDA will not be able to complete the review of MannKind’s new drug application (NDA) for its ultra rapid-acting insulin therapy by the action date of January 16, 2010.

In response to the recent Food and Drug Administration action, Evanger's Dog and Cat Food Co., Inc. has filed a formal request, as allowed by FDA regulations, for reinstatement based on documentation that the company is operating in full compliance with mandatory requirements. "Our company has been working closely with the FDA and we have already addressed many of their questions," says Joel Sher, Vice President of Evanger's.

The American Public Health Association (APHA) today applauded the U.S. House of Representatives for passing the Family Smoking Prevention and Tobacco Control Act. The legislation aims to protect the health of Americans, particularly children, by giving the Food and Drug Administration (FDA) the authority to regulate tobacco products.